What is PT-141?
PT-141, also known as Bremelanotide, is a synthetic peptide derived from Melanotan II. It was developed primarily for its ability to enhance sexual function and arousal in both men and women.
Mechanisms of Action
Melanocortin receptor activation in the brain that targets pathways involved in arousal and libido.
Vasodilation that increases blood flow to genital tissues, supporting physical signs of arousal and responsiveness.
Neurological effects that modulate neurotransmitter pathways tied to sexual desire and behavior, operating outside traditional hormonal mechanisms.
Benefits
Improved sexual function outcomes discussed in erectile dysfunction (ED) research in men and hypoactive sexual desire disorder (HSDD) research in women.
Enhanced libido and arousal signals in individuals with low sexual desire.
Non-hormonal therapeutic profile that works independently of hormones like testosterone or estrogen.
Dosing
Strength | Dose |
|---|---|
Low | 0.5 mg per use |
Medium | 1.0 mg per use |
High | 1.75 mg per use |
Common administration framing in the source material: subcutaneous injection as needed, typically 30 to 60 minutes before anticipated activity, with frequency adjusted based on response and tolerability.
Safety Profile
PT-141 is generally described as well tolerated when used at recommended doses. Commonly reported side effects include nausea, headache, and flushing. These effects are typically mild and transient, and medical guidance is recommended prior to initiation to support appropriate monitoring and safety.
Stacking
Sexual Support Stack
PT-141
Oxytocin
Taladafinil
Zofran
Disclaimer: The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. All compounds referenced are not for human consumption.
